BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

493 related articles for article (PubMed ID: 20889904)

  • 1. Experimental rhinovirus infection as a human model of chronic obstructive pulmonary disease exacerbation.
    Mallia P; Message SD; Gielen V; Contoli M; Gray K; Kebadze T; Aniscenko J; Laza-Stanca V; Edwards MR; Slater L; Papi A; Stanciu LA; Kon OM; Johnson M; Johnston SL
    Am J Respir Crit Care Med; 2011 Mar; 183(6):734-42. PubMed ID: 20889904
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oxidative and Nitrosative Stress and Histone Deacetylase-2 Activity in Exacerbations of COPD.
    Footitt J; Mallia P; Durham AL; Ho WE; Trujillo-Torralbo MB; Telcian AG; Del Rosario A; Chang C; Peh HY; Kebadze T; Aniscenko J; Stanciu L; Essilfie-Quaye S; Ito K; Barnes PJ; Elkin SL; Kon OM; Wong WS; Adcock IM; Johnston SL
    Chest; 2016 Jan; 149(1):62-73. PubMed ID: 25790167
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rhinovirus infection induces degradation of antimicrobial peptides and secondary bacterial infection in chronic obstructive pulmonary disease.
    Mallia P; Footitt J; Sotero R; Jepson A; Contoli M; Trujillo-Torralbo MB; Kebadze T; Aniscenko J; Oleszkiewicz G; Gray K; Message SD; Ito K; Barnes PJ; Adcock IM; Papi A; Stanciu LA; Elkin SL; Kon OM; Johnson M; Johnston SL
    Am J Respir Crit Care Med; 2012 Dec; 186(11):1117-24. PubMed ID: 23024024
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bronchial mucosal inflammation and illness severity in response to experimental rhinovirus infection in COPD.
    Zhu J; Mallia P; Footitt J; Qiu Y; Message SD; Kebadze T; Aniscenko J; Barnes PJ; Adcock IM; Kon OM; Johnson M; Contoli M; Stanciu LA; Papi A; Jeffery PK; Johnston SL
    J Allergy Clin Immunol; 2020 Oct; 146(4):840-850.e7. PubMed ID: 32283204
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of airway glucose in bacterial infections in patients with chronic obstructive pulmonary disease.
    Mallia P; Webber J; Gill SK; Trujillo-Torralbo MB; Calderazzo MA; Finney L; Bakhsoliani E; Farne H; Singanayagam A; Footitt J; Hewitt R; Kebadze T; Aniscenko J; Padmanaban V; Molyneaux PL; Adcock IM; Barnes PJ; Ito K; Elkin SL; Kon OM; Cookson WO; Moffat MF; Johnston SL; Tregoning JS
    J Allergy Clin Immunol; 2018 Sep; 142(3):815-823.e6. PubMed ID: 29310905
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lymphocyte subsets in experimental rhinovirus infection in chronic obstructive pulmonary disease.
    Mallia P; Message SD; Contoli M; Gray K; Telcian A; Laza-Stanca V; Papi A; Stanciu LA; Elkin S; Kon OM; Johnson M; Johnston SL
    Respir Med; 2014 Jan; 108(1):78-85. PubMed ID: 24099891
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum IP-10 as a biomarker of human rhinovirus infection at exacerbation of COPD.
    Quint JK; Donaldson GC; Goldring JJ; Baghai-Ravary R; Hurst JR; Wedzicha JA
    Chest; 2010 Apr; 137(4):812-22. PubMed ID: 19837822
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antiviral immunity is impaired in COPD patients with frequent exacerbations.
    Singanayagam A; Loo SL; Calderazzo M; Finney LJ; Trujillo Torralbo MB; Bakhsoliani E; Girkin J; Veerati P; Pathinayake PS; Nichol KS; Reid A; Footitt J; Wark PAB; Grainge CL; Johnston SL; Bartlett NW; Mallia P
    Am J Physiol Lung Cell Mol Physiol; 2019 Dec; 317(6):L893-L903. PubMed ID: 31513433
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An experimental model of rhinovirus induced chronic obstructive pulmonary disease exacerbations: a pilot study.
    Mallia P; Message SD; Kebadze T; Parker HL; Kon OM; Johnston SL
    Respir Res; 2006 Sep; 7(1):116. PubMed ID: 16956406
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Experimental rhinovirus infection in COPD: implications for antiviral therapies.
    Gunawardana N; Finney L; Johnston SL; Mallia P
    Antiviral Res; 2014 Feb; 102():95-105. PubMed ID: 24370732
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of interactions between lower airway bacterial and rhinoviral infection in exacerbations of COPD.
    Wilkinson TMA; Hurst JR; Perera WR; Wilks M; Donaldson GC; Wedzicha JA
    Chest; 2006 Feb; 129(2):317-324. PubMed ID: 16478847
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Exacerbations of chronic obstructive pulmonary disease.
    Wedzicha JA; Donaldson GC
    Respir Care; 2003 Dec; 48(12):1204-13; discussion 1213-5. PubMed ID: 14651761
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Outgrowth of the bacterial airway microbiome after rhinovirus exacerbation of chronic obstructive pulmonary disease.
    Molyneaux PL; Mallia P; Cox MJ; Footitt J; Willis-Owen SA; Homola D; Trujillo-Torralbo MB; Elkin S; Kon OM; Cookson WO; Moffatt MF; Johnston SL
    Am J Respir Crit Care Med; 2013 Nov; 188(10):1224-31. PubMed ID: 23992479
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A human rhinovirus model of chronic obstructive pulmonary disease exacerbations.
    Contoli M; Caramori G; Mallia P; Papi A; Johnston SL
    Contrib Microbiol; 2007; 14():101-112. PubMed ID: 17684335
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human rhinovirus proteinase 2A induces TH1 and TH2 immunity in patients with chronic obstructive pulmonary disease.
    Singh M; Lee SH; Porter P; Xu C; Ohno A; Atmar RL; Greenberg SB; Bandi V; Gern J; Amineva S; Aminev A; Skern T; Smithwick P; Perusich S; Barrow N; Roberts L; Corry DB; Kheradmand F
    J Allergy Clin Immunol; 2010 Jun; 125(6):1369-1378.e2. PubMed ID: 20430426
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lower airway rhinovirus burden and the seasonal risk of asthma exacerbation.
    Denlinger LC; Sorkness RL; Lee WM; Evans MD; Wolff MJ; Mathur SK; Crisafi GM; Gaworski KL; Pappas TE; Vrtis RF; Kelly EA; Gern JE; Jarjour NN
    Am J Respir Crit Care Med; 2011 Nov; 184(9):1007-14. PubMed ID: 21816938
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human rhinovirus infection during naturally occurring COPD exacerbations.
    George SN; Garcha DS; Mackay AJ; Patel AR; Singh R; Sapsford RJ; Donaldson GC; Wedzicha JA
    Eur Respir J; 2014 Jul; 44(1):87-96. PubMed ID: 24627537
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human rhinovirus infection and COPD: role in exacerbations and potential for therapeutic targets.
    Cafferkey J; Coultas JA; Mallia P
    Expert Rev Respir Med; 2020 Aug; 14(8):777-789. PubMed ID: 32498634
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Comparison of the detection rate and load of rhinovirus in nasal versus lower airway samples from patients with chronic obstructive pulmonary disease].
    Liao H; Chen R; Guan W; Yang Z; Liu W; Zhou R; Zhong N
    Zhonghua Jie He He Hu Xi Za Zhi; 2014 Jan; 37(1):21-3. PubMed ID: 24694969
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detection of rhinovirus in induced sputum at exacerbation of chronic obstructive pulmonary disease.
    Seemungal TA; Harper-Owen R; Bhowmik A; Jeffries DJ; Wedzicha JA
    Eur Respir J; 2000 Oct; 16(4):677-83. PubMed ID: 11106212
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.